The fact that early treatment was associated with a lower long-term risk of psychosis suggests these medications may do more ...
Medical Device Network on MSN
Cerebral acquires Inflow to broaden mental health platform’s ADHD toolkit
Cerebral’s acquisition of Inflow equips the company with digital therapeutic tools designed to help patients manage their ...
A new study, led by scientists at University College Dublin and the University of Edinburgh, has found that commonly prescribed attention deficit hyperactivity disorder (ADHD) medication in childhood ...
Children who received certain types of medication for attention-deficit/hyperactivity disorder at a young age may be less ...
The acquisition allows Cerebral to offer ADHD patients ongoing support through therapy, skill-building modules, medication ...
A breakthrough in treating attention-deficit/hyperactivity disorder could “significantly improve” the lives of children with the condition, experts said. A new ...
Attention-deficit/hyperactivity disorder (ADHD) is a common but complex neurodevelopmental condition characterized by symptoms of inattention, hyperactivity, and ...
Adult ADHD treatment surges as stimulant prescriptions more than double since the COVID-19 pandemic began, as a new study ...
ADHD in females often manifests itself in behaviors not usually associated with the disorder. The women tend to be ...
Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental condition that causes hyperactivity and impulsivity in children and adults. If left untreated ...
You’re smart and capable—but staying organized, managing time, or regulating emotions feels harder than it should. You may have ADHD or struggle with focus, motivation, or follow-through. You’re tired ...
A large, new study found that the stimulant methylphenidate, such as the drugs Ritalin and Concerta, may lower the risk of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results